At close: December 13 at 4:00:00 PM EST
Pre-Market: 4:10:24 AM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | -- | 2 | 2 |
| Avg. Estimate | -1.1 | 0 | -2.46 | -2.52 |
| Low Estimate | -1.65 | 0 | -2.77 | -2.92 |
| High Estimate | -0.54 | 0 | -2.16 | -2.12 |
| Year Ago EPS | -0.8 | -- | -5.1 | -2.46 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | -- | 2 | 2 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | -- | 0.00% | 0.00% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -1.1 | -1.15 | -0.87 | -0.4 |
| EPS Actual | -0.8 | -2.8 | -1.06 | -0.67 |
| Difference | 0.3 | -1.65 | -0.19 | -0.27 |
| Surprise % | 27.27% | -143.48% | -22.31% | -66.76% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -1.1 | 0 | -2.46 | -2.52 |
| 7 Days Ago | -0.4 | 0 | -5.5 | -2.4 |
| 30 Days Ago | -0.4 | 0 | -5.5 | -2.4 |
| 60 Days Ago | -0.4 | 0 | -6 | -2.4 |
| 90 Days Ago | -0.35 | 0 | -4.67 | -2.1 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 2 | -- | 1 | 2 |
| Up Last 30 Days | 2 | -- | 1 | 2 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| PHGE | -36.87% | -- | 51.67% | -2.23% |
| S&P 500 | 5.00% | 12.00% | 2.10% | 12.20% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/16/2024 |
| Initiated | Laidlaw & Co.: Buy | 5/28/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/21/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/22/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/3/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/7/2024 |
Related Tickers
ARMP Armata Pharmaceuticals, Inc.
2.1918
+4.37%
VIGL Vigil Neuroscience, Inc.
1.9900
-0.50%
SLGL Sol-Gel Technologies Ltd.
0.4795
+2.68%
DNTH Dianthus Therapeutics, Inc.
23.81
+1.32%
COEP Coeptis Therapeutics Holdings, Inc.
0.1779
-4.35%
TG1N.F Armata Pharmaceuticals, Inc.
1.9800
+3.66%
OCEAW Ocean Biomedical, Inc.
0.0325
+25.00%
ALDVI.PA Advicenne S.A.
1.7100
+0.59%
PHXM.PA PHAXIAM Therapeutics S.A.
1.7020
-1.96%
NCNA NuCana plc
1.2700
+1.60%